Organization · Private Equity
Montreux Growth Partners
Montreux Growth Partners is a growth capital investment firm based in the United States, focusing on commercial stage companies in the healthcare and financial technology sectors. They typically invest in companies with annual revenues between $5 to $50 million.
Overview
What Montreux Growth Partners does
What Montreux Growth Partners is
Montreux Growth Partners is a growth capital investment firm based in the United States, focusing on commercial stage companies in the healthcare and financial technology sectors. They typically invest in companies with annual revenues between $5 to $50 million.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Montreux Growth Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Montreux Growth Partners as a funder
Investment thesis
Montreux Growth Partners invests in high growth, commercial stage companies with category-leading products, technologies, and services, primarily in healthcare and financial technology.
Focus narrative
Montreux Growth Partners invests in high growth, commercial stage companies with category-leading products, technologies, and services. The firm primarily focuses on the healthcare and financial technology sectors.
Terms and economics
- Typical check
- $10,000,000–$20,000,000
Focus and fit
- Stages
- Growth Equity
- Sectors
- HealthcareFintech
- Regions
- United States
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Montreux Growth Partners has a diverse portfolio that includes notable companies such as TigerConnect, a clinical communications and collaboration platform for healthcare; SenoRx, a specialty pharmaceutical company focused on dermatology; MD Tech, the largest provider of business management software for the beauty, health, and wellness sectors; Glooko, a leading medical device solution for the treatment of glaucoma; SIBN, a leader in the treatment of the Sacroiliac joint and low back pain; TBRA, innovative treatments for HIV and liver disease; LUNG, a leading minimally invasive treatment for emphysema; and OREX, a company focused on the treatment of obesity. The firm has also been involved in several acquisitions, including companies acquired by Allergan, Stryker, and Johnson & Johnson.
Common questions
What to know about Montreux Growth Partners
Upseed classifies Montreux Growth Partners under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.